Drug Safety Concerns: Four Indian Pharma Companies Issue Recalls in Last Three Months
It’s been a rough start to 2025 for Indian pharmaceutical giants. Four of India’s biggest generic drug producers issued product recalls in the last three months.
CPA Recommendations for Implementing Tariffs Pursuant to the America First Trade Policy Memorandum
CPA cautions against adopting a reciprocal tariff strategy aimed primarily at negotiating lower foreign trade barriers and more favorable investment conditions abroad. A reciprocal tariff strategy that prioritizes foreign governments’ willingness to reduce their trade barriers or be more receptive to foreign investment is in conflict with the stated goals of the America First Trade Policy Memorandum and undermines the predictability and stability American businesses need to confidently invest in long-term domestic production.
Why Overhauling Global Trade Rules Is a Long-Term Challenge, Not a Two-Month Fix
It took nine months to rescue two astronauts stuck on the International Space Station this weekend, yet somehow President Trump is expected to rewrite global trade rules between the U.S. and 166 World Trade Organization-member countries in less than two months.
CPA Highlights Critical Role of NSF and NIH in Driving U.S. Innovation and Industrial Leadership
Strong federal investment in the National Science Foundation and National Institutes of Health is vital for American innovation, economic growth, and national security.
CPA Economist: Tariffs Don’t Drive Inflation
Tariffs are an effective tool for boosting domestic production. They stimulate critical domestic investment and increase U.S. manufacturing capacity. It’s past time to abandon the outdated dogma of unregulated free trade — and start focusing on rebuilding American industry to create jobs and ensure long-term economic resilience.
House Select Committee on CCP Hears Testimony From 9 Companies Detailing Their Struggles Against Chinese Trade Violators
Nine different companies joined members of the House Select Committee on China at a press conference on Wednesday to talk about their battles with “China trade cheats” that have cost them a fortune. Most of them closed factories, or rolled back investment. Despite tariffs and anti-dumping (AD/CVD) trade case victories, the battle continues.
New CPA Economic Report Highlights Importance of President Trump’s Steel and Aluminum Tariffs
CPA’s report demonstrates that previous tariff exemptions and exclusions significantly weakened the effectiveness of the original tariffs imposed in 2018.
House Oversight Hearing Slams Inflation Reduction Act, But Ignores China’s Role
In a House Oversight subcommittee hearing on Feb. 26, the Inflation Reduction Act (IRA) was hit with the usual swipes from detractors, with some calling it the “green scam”, but China’s solar company benefits were never mentioned.
China Drug Exports to U.S. Rise as America Reaches a Crossroads in Its Own Supply Shortfalls
In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.
CPA Announces Leadership Changes as CEO Michael Stumo Joins Trump Administration
CPA announced key leadership changes as CEO Michael Stumo steps down to take on a new role in the Trump administration. Jon Toomey has been elevated as President of CPA to lead the organization and Nick Iacovella has been promoted to Executive Vice President.
